Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial.

Bobo WV, Reilly-Harrington NA, Ketter TA, Brody BD, Kinrys G, Kemp DE, Shelton RC, McElroy SL, Sylvia LG, Kocsis JH, McInnis MG, Friedman ES, Singh V, Tohen M, Bowden CL, Deckersbach T, Calabrese JR, Thase ME, Nierenberg AA, Rabideau DJ, Schoenfeld DA, Faraone SV, Kamali M.

J Affect Disord. 2014 Jun;161:30-5. doi: 10.1016/j.jad.2014.02.046. Epub 2014 Mar 13.

2.

Combination antidepressant therapy for major depressive disorder: speed and probability of remission.

Stewart JW, McGrath PJ, Blondeau C, Deliyannides DA, Hellerstein D, Norris S, Amat J, Pilowsky DJ, Tessier P, Laberge L, O'Shea D, Chen Y, Withers A, Bergeron R, Blier P.

J Psychiatr Res. 2014 May;52:7-14. doi: 10.1016/j.jpsychires.2013.12.001. Epub 2013 Dec 17.

PMID:
24485847
3.

Prescribing patterns of lithium or lithium+valproate in manic or mixed episodes: a naturalistic study.

Muti M, Del Grande C, Musetti L, Marazziti D, Pergentini I, Corsi M, Turri M, Umberto Corsini G, Dell'Osso L.

Int Clin Psychopharmacol. 2013 Nov;28(6):305-11. doi: 10.1097/YIC.0b013e3283642348.

PMID:
23873290
4.

Higher pretreatment 5-HT1A receptor binding potential in bipolar disorder depression is associated with treatment remission: a naturalistic treatment pilot PET study.

Lan MJ, Hesselgrave N, Ciarleglio A, Ogden RT, Sullivan GM, Mann JJ, Parsey RV.

Synapse. 2013 Nov;67(11):773-8. doi: 10.1002/syn.21684. Epub 2013 Jun 17.

5.
6.

Post-acute effectiveness of lithium in pediatric bipolar I disorder.

Findling RL, Kafantaris V, Pavuluri M, McNamara NK, Frazier JA, Sikich L, Kowatch R, Rowles BM, Clemons TE, Taylor-Zapata P.

J Child Adolesc Psychopharmacol. 2013 Mar;23(2):80-90. doi: 10.1089/cap.2012.0063.

7.

Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium.

Nierenberg AA, Friedman ES, Bowden CL, Sylvia LG, Thase ME, Ketter T, Ostacher MJ, Leon AC, Reilly-Harrington N, Iosifescu DV, Pencina M, Severe JB, Calabrese JR.

Am J Psychiatry. 2013 Jan;170(1):102-10. doi: 10.1176/appi.ajp.2012.12060751.

PMID:
23288387
8.

Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice.

Kulkarni J, Filia S, Berk L, Filia K, Dodd S, de Castella A, Brnabic AJ, Lowry AJ, Kelin K, Montgomery W, Fitzgerald PB, Berk M.

BMC Psychiatry. 2012 Dec 17;12:228. doi: 10.1186/1471-244X-12-228.

9.

Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial.

Berk M, Dean OM, Cotton SM, Gama CS, Kapczinski F, Fernandes B, Kohlmann K, Jeavons S, Hewitt K, Moss K, Allwang C, Schapkaitz I, Cobb H, Bush AI, Dodd S, Malhi GS.

BMC Med. 2012 Aug 14;10:91. doi: 10.1186/1741-7015-10-91.

10.

A preliminary open trial of nefazodone added to mood stabilizers for bipolar depression.

Goldberg JF.

J Affect Disord. 2013 Jan 10;144(1-2):176-8. doi: 10.1016/j.jad.2012.04.037. Epub 2012 Aug 1.

PMID:
22858262
11.

Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.

Alevizos B, Alevizos E, Leonardou A, Zervas I.

Psychiatriki. 2012 Apr-Jun;23(2):143-8.

PMID:
22796912
12.

Four hygienic-dietary recommendations as add-on treatment in depression: a randomized-controlled trial.

García-Toro M, Ibarra O, Gili M, Serrano MJ, Oliván B, Vicens E, Roca M.

J Affect Disord. 2012 Oct;140(2):200-3. doi: 10.1016/j.jad.2012.03.031. Epub 2012 Apr 18.

PMID:
22516309
13.

Relationship of prior antidepressant exposure to long-term prospective outcome in bipolar I disorder outpatients.

Post RM, Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Nolen WA, Rowe M, Kupka RW, Grunze H, Goodwin FK.

J Clin Psychiatry. 2012 Jul;73(7):924-30. doi: 10.4088/JCP.11m07396. Epub 2012 Mar 20.

PMID:
22480597
14.

Proposed DSM-5 mixed features are associated with greater likelihood of remission in out-patients with major depressive disorder.

Perlis RH, Cusin C, Fava M.

Psychol Med. 2014 May;44(7):1361-7. doi: 10.1017/S0033291712000281. Epub 2012 Mar 15.

PMID:
22417535
15.

Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial.

Anand A, Gunn AD, Barkay G, Karne HS, Nurnberger JI, Mathew SJ, Ghosh S.

Bipolar Disord. 2012 Feb;14(1):64-70. doi: 10.1111/j.1399-5618.2011.00971.x.

PMID:
22329473
16.

Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up.

Mazza M, Mandelli L, Zaninotto L, Nicola MD, Martinotti G, Harnic D, Bruschi A, Catalano V, Tedeschi D, Colombo R, Bria P, Serretti A, Janiri L.

Int J Psychiatry Clin Pract. 2012 Jun;16(2):113-20. doi: 10.3109/13651501.2011.633171. Epub 2012 Feb 1.

PMID:
22296514
17.

Long-term worsening of bipolar disorder related with frequency of antidepressant exposure.

Strejilevich SA, Martino DJ, Marengo E, Igoa A, Fassi G, Whitham EA, Ghaemi SN.

Ann Clin Psychiatry. 2011 Aug;23(3):186-92.

PMID:
21808750
18.

Dosing strategies for lithium monotherapy in children and adolescents with bipolar I disorder.

Findling RL, Kafantaris V, Pavuluri M, McNamara NK, McClellan J, Frazier JA, Sikich L, Kowatch R, Lingler J, Faber J, Rowles BM, Clemons TE, Taylor-Zapata P.

J Child Adolesc Psychopharmacol. 2011 Jun;21(3):195-205. doi: 10.1089/cap.2010.0084.

19.

Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year.

Cristancho P, Cristancho MA, Baltuch GH, Thase ME, O'Reardon JP.

J Clin Psychiatry. 2011 Oct;72(10):1376-82. doi: 10.4088/JCP.09m05888blu.

PMID:
21295002
20.

Autonomic nervous system in euthymic patients with bipolar affective disorder.

Latalova K, Prasko J, Diveky T, Grambal A, Kamaradova D, Velartova H, Salinger J, Opavsky J.

Neuro Endocrinol Lett. 2010;31(6):829-36.

PMID:
21196931
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk